GL1X · GenesisL1 explorer

MolNFT v1 · #143937 · protein

Crystal structure of vacv D13 in complex with rifampicin

6BED · Scaffold protein D13: “Crystal structure of vacv D13 in complex with rifampicin”. X-ray diffraction, 1 ligand (RFP), 20 pockets (best druggability 0.83). MolNFT v1 #143937 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6BED
Type
protein
Length
1,615 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Scaffold protein D13
UniProt
P68440
Ligands
RFP
Pockets
20 · best druggability 0.83

Structure

x-ray diffraction · 3 distinct chains · 16% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AScaffold protein D13protein54217% helix, 40% strandP68440
BScaffold protein D13protein54316% helix, 40% strandP68440
CScaffold protein D13protein53015% helix, 41% strandP68440

Ligands and binding sites

  • RFP · Rifampicin · ligand · chains A, B, C
  • FMT · Formic acid · additive · 15 copies · chains A, B, C
  • EDO · 1,2-ethanediol · additive · 10 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110230.830.8494empty
210010.830.84103FMT, EDO
39550.830.85107FMT
44560.630.7753empty
51200.530.8225FMT, EDO

Interfaces

3 interfaces between chains.

  • A–B · 3000 Ų buried · 32 hydrogen bonds · protein-protein
  • B–C · 2763 Ų buried · 33 hydrogen bonds · protein-protein
  • A–C · 2461 Ų buried · 33 hydrogen bonds · protein-protein

Compared structures

  • 6BED · Crystal structure of VACV D13 in complex with Rifampicin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.